Log in to save to my catalogue

Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with e...

Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with e...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11402380

Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study

About this item

Full title

Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study

Publisher

United States: Elsevier Limited

Journal title

Biomedical journal, 2024-10, Vol.47 (5), p.100680

Language

English

Formats

Publication information

Publisher

United States: Elsevier Limited

More information

Scope and Contents

Contents

The clinical value of therapeutic drug monitoring (TDM) for newer anti-seizure medications (ASMs) remains uncertain. This study aimed to assess the impact of newer ASM TDM on clinical decision making in patients with epilepsy.
We retrospectively identified all plasma requests for newer ASM level measurement as part of routine clinical management...

Alternative Titles

Full title

Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11402380

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11402380

Other Identifiers

ISSN

2319-4170,2320-2890

E-ISSN

2320-2890

DOI

10.1016/j.bj.2023.100680

How to access this item